Other Species / Isoforms
  ELAVL2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T51-p
NYLPQNMtQEELKSL
0 1
ELAVL2 (human) NYLPQNMtQEELKSL T51-p
ELAVL2 (mouse) NYLPQNMTQEELKSL T51
ELAVL2 (rat) NYLPQNMTQEELKSL T51
K74-ub
SCKLVRDkITGQSLG
0 2
ELAVL2 (human) SCKLVRDkITGQSLG K74-ub
ELAVL2 (mouse) SCKLVRDkITGQSLG K74-ub
ELAVL2 (rat) SCKLVRDKITGQSLG K74
K95-ub
IDPKDAEkAINTLNG
0 2
ELAVL2 (human) IDPKDAEkAINTLNG K95-ub
ELAVL2 (mouse) IDPKDAEkAINTLNG K95-ub
ELAVL2 (rat) IDPKDAEKAINTLNG K95
S119-p
VSYARPSsASIRDAN
0 2
ELAVL2 (human) VSYARPSsASIRDAN S119-p
ELAVL2 (mouse) VSYARPSsASIRDAN S119-p
ELAVL2 (rat) VSYARPSSASIRDAN S119
T162-p
RILVDQVtGIsRGVG
0 2
ELAVL2 (human) RILVDQVtGIsRGVG T162-p
ELAVL2 (mouse) RILVDQVtGIsRGVG T162-p
ELAVL2 (rat) RILVDQVTGISRGVG T162
S165-p
VDQVtGIsRGVGFIR
0 2
ELAVL2 (human) VDQVtGIsRGVGFIR S165-p
ELAVL2 (mouse) VDQVtGIsRGVGFIR S165-p
ELAVL2 (rat) VDQVTGISRGVGFIR S165
K209-ub
FANNPSQkTNQAILS
0 12
ELAVL2 (human) FANNPSQkTNQAILS K209-ub
ELAVL2 (mouse) FANNPSQkTNQAILS K209-ub
ELAVL2 (rat) FANNPSQkTNQAILS K209-ub
Y219
QAILSQLYQsPNRRY
0 1
ELAVL2 (human) QAILSQLYQsPNRRY Y219
ELAVL2 (mouse) QAILSQLyQsPNRRY Y219-p
ELAVL2 (rat) QAILSQLYQsPNRRY Y219
S221-p
ILSQLYQsPNRRYPG
Upstream
0 28
Treatment
  • nocodazole
ELAVL2 (human) ILSQLYQsPNRRYPG S221-p
ELAVL2 (mouse) ILSQLyQsPNRRYPG S221-p
ELAVL2 (rat) ILSQLYQsPNRRYPG S221-p
R236
PLAQQAQRFRLDNLL
0 2
ELAVL2 (human) PLAQQAQRFRLDNLL R236
ELAVL2 (mouse) PLAQQAQrFRLDNLL R236-m2
ELAVL2 (rat) PLAQQAQRFRLDNLL R236
K315-ub
IRDFNTNkCKGFGFV
0 6
ELAVL2 (human) IRDFNTNkCKGFGFV K315-ub
ELAVL2 (mouse) IRDFNTNkCKGFGFV K316-ub
ELAVL2 (rat) IRDFNTNKCKGFGFV K315